Pharma News, 2016

For the third straight quarter, GlaxoSmithKline CEO Andrew Witty is sticking it to his critics.

Merck & Co.

Alkermes stock surged more than 27 percent Friday after its depression drug met its main goal in a final-stage study.

International pharmaceutical company Merck has announced that the U.

CAMBRIDGE, MA, USA I October 21, 2016 I Boston Biomedical, an industry leader in the development of novel compounds designed to target cancer stemness pathways, today announced dosing of the first pat...

SAN DIEGO, CA, USA I October 24, 2016 I Ligand Pharmaceuticals Incorporated (NASDAQ.

As of today, the European Medicines Agency (EMA) gives open access to clinical reports for new medicines for human use authorised in the European Union (EU).

 While the rate of tuberculosis in the United States has fallen over the past 20 years, worldwide, it remains a leading cause of death.

JERUSALEM, Israel I October 20, 2016 I Teva Pharmaceutical Industries Ltd.

Facing “very low market demand,” GlaxoSmithKline has decided to pull out of the U.

Researchers hope this new treatment could be administered as simple nasal spray.

Last week’s NICE rejection of Opdivo for routine use in lung cancer patients has presented BMS with another setback – and an opportunity for Merck Sharp & Dohme (Merck in the US) and i...